5,052
Views
3
CrossRef citations to date
0
Altmetric
Original Contributions

Paramedic-Delivered Fibrinolysis in the Treatment of ST-Elevation Myocardial Infarction: Comparison of a Physician-Authorized versus Autonomous Paramedic Approach

Pages 617-624 | Received 23 Aug 2019, Accepted 18 Oct 2019, Published online: 13 Nov 2019

References

  • ST-Elevation Myocardial Infarction Guidelines Group and the New Zealand Branch of the Cardiac Society of Australia and New Zealand. ST-elevation myocardial infarction: New Zealand management guidelines, 2013. N Z Med J. 2013;126(1387):127–64.
  • Bongard V, Puel J, Savary D, Belle L, Charpentier S, Cottin Y, Soulat L, Elbaz M, Miljkovic D, Steg PG. Predictors of infarct artery patency after prehospital thrombolysis: the multicentre, prospective, observational OPTIMAL study. Heart. 2009;95:799–806. doi:10.1136/hrt.2008.152504.
  • Verheugt FWA, Gersh BJ, Armstrong PW. Aborted myocardial infarction: a new target for reperfusion therapy. Eur Heart J. 2006;27:901–4. doi:10.1093/eurheartj/ehi829.
  • Björklund E, Stenestrand U, Lindbäck J, Svensson L, Wallentin L, Lindahl B. Pre-hospital thrombolysis delivered by paramedics is associated with reduced time delay and mortality in ambulance-transported real-life patients with ST-elevation myocardial infarction. Eur Heart J. 2006;27:1146–52. doi:10.1093/eurheartj/ehi886.
  • Ranchord AM, Prasad S, Matsis P, Harding SA. Paramedic-administered prehospital thrombolysis is safe and reduces time to treatment. N Z Med J. 2009;122:47–53.
  • Danchin N, Durand E, Blanchard D. Pre-hospital thrombolysis in perspective. Eur Heart J. 2008;29:2835–42. doi:10.1093/eurheartj/ehn462.
  • Davis P. Northland and Hawkes Bay prehospital paramedic fibrinolysis programme: audit report 2014. Whangarei (New Zealand): St John; 2014.
  • Keeling P, Hughes D, Price L, Shaw S, Barton A. Safety and feasibility of prehospital thrombolysis carried out by paramedics. BMJ. 2003;327:27–8. doi:10.1136/bmj.327.7405.27.
  • McLean S, Egan G, Connor P, Flapan AD. Collaborative decision-making between paramedics and CCU nurses based on 12-lead ECG telemetry expedites the delivery of thrombolysis in ST elevation myocardial infarction. Emerg Med J. 2008;25:370–4. doi:10.1136/emj.2007.052746.
  • Grijseels EWM, Bouten MJM, Lenderink T, Deckers JW, Hoes AW, Hartman JAM, Van der Does E, Simoons ML. Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Eur Heart J. 1995;16:1833–8. doi:10.1093/oxfordjournals.eurheartj.a060836.
  • Pitt K. Prehospital selection of patients for thrombolysis by paramedics. Practical applications, complications and long-term results in 529 patients. Emerg Med J. 2002;19:260–3. doi:10.1136/emj.19.3.260.
  • Statistics New Zealand. Subnational population estimates (UA, AU), by age and sex, at 30 June 1996, 2001, 2006-16 (2017 boundary). 2017 [accessed 2018 Jan 9]. http://nzdotstat.stats.govt.nz/wbos/Index.aspx?DataSetCode=TABLECODE7541.
  • Faul F, Erdfelder E, Lang A, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–91. doi:10.3758/BF03193146.
  • McCaul M, Lourens A, Kredo T. Cochrane corner: prehospital versus in-hospital thrombolysis for ST-elevation myocardial infarction. Heart. 2015;101:1857–58. doi:10.1136/heartjnl-2015-307779.
  • Weaver DW. Time to thrombolytic treatment: factors affecting delay and their influence on outcome. J Am Coll Cardiol. 1995;25:S3–S9. doi:10.1016/0735-1097(95)90010-1.
  • Danchin N, Blanchard D, Steg PG, Sauval P, Hanania G, Goldstein P, Cambou J-P, Guéret P, Vaur L, Boutalbi Y, et al. Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome. Circulation. 2004;110:1909–15. doi:10.1161/01.CIR.0000143144.82338.36.
  • Oldgren J, Wernroth L, Stenestrand U. Fibrinolytic therapy and bleeding complications: risk predictors from RIKS-HIA. Heart. 2010;96:1451–7. doi:10.1136/hrt.2009.188243.
  • Schulman SP, Beyth RJ, Kearon C, Levine MN. Hemorrhagic complications of anticoagulant and thrombolytic treatment*. Chest. 2008;133:257S–98S. doi:10.1378/chest.08-0674.
  • Fibrinolytic Therapy Trialists’ Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343:311–22.
  • Feldman JA, Brinsfield K, Bernard S, White D, Maciejko T. Real-time paramedic compared with blinded physician identification of ST-segment elevation myocardial infarction: results of an observational study. Am J Emerg Med. 2005;23:443–8. doi:10.1016/j.ajem.2004.10.011.
  • Whitbread M, Leah LV, Bell T, Coats TJ. Recognition of ST elevation by paramedics. Emerg Med J. 2002;19:66–7. doi:10.1136/emj.19.1.66.
  • Jain S, Ting HT, Bell M, Bjerke CM, Lennon RJ, Gersh BJ, Rihal CS, Prasad A. Utility of left bundle branch block as a diagnostic criterion for acute myocardial infarction. Am J Cardiol. 2011;107:1111–6. doi:10.1016/j.amjcard.2010.12.007.
  • Kontos MC, Aziz HA, Chau VQ, Roberts CS, Ornato JP, Vetrovec GW. Outcomes in patients with chronicity of left bundle-branch block with possible acute myocardial infarction. Am Heart J. 2011;161:698–704. doi:10.1016/j.ahj.2011.01.008.
  • National Ambulance Sector Clinical Working Group. Clinical procedures and guidelines: comprehensive edition 2016-2018. 2016. [accessed 2017 Jan 9] https://www.stjohn.org.nz/globalassets/documents/health-practitioners/cpg_comprehensive_web170525.pdf.
  • Tanner H, Larsen P, Lever N, Galletly D. Early recognition and early access for acute coronary syndromes in New Zealand: key links in the chain of survival. N Z Med J. 2006;119:38–46.
  • New Zealand National Cardiac Network. New Zealand out-of-hospital STEMI pathway. Wellington (New Zealand): New Zealand Ministry of Health; 2016.